◆ FUNDING DATA
- Round
- Series C
- Founded
- 2015
- Location
- Cambridge, United Kingdom
- Headcount
- 33
- Priority score
- 75/100
- Confidence
- 70/100
Series C⬢ HOT
Storm Therapeutics.
STORM Therapeutics develops novel small molecule therapies targeting RNA modifying enzymes for oncology and other diseases, with lead product STC-15 in clinical development.